<DOC>
	<DOCNO>NCT00912938</DOCNO>
	<brief_summary>evaluate whether bone marker provide valuable predictor skeletal complication whether regular assess NTX ( N-telopeptide type I collagen ) osteocalcin useful advanced breast cancer patient bone metastasis receive zoledronic acid .</brief_summary>
	<brief_title>Evaluate Relationship Bone Remodeling Markers Skeletal Complications Metastatic Breast Cancer Patients</brief_title>
	<detailed_description>evaluate efficacy safety zoledronic acid measuring change bone turnover marker - incidence skeletal-related event - time skeletal-related event - time bone metastases progression - overall survival - incidence adverse event include osteonecrosis</detailed_description>
	<mesh_term>Breast Neoplasms</mesh_term>
	<mesh_term>Zoledronic acid</mesh_term>
	<mesh_term>Diphosphonates</mesh_term>
	<criteria>1 . Patients advance breast cancer radiographic confirmation bone metastasis ( minimum one bone scan lesion must confirm metastatic plain radiograph CT/MR imaging ) 2 . Men woman age â‰¥ 18 year 3. WHO ( ECOG ) performance status 02 4 . Women childbearing potential must use reliable appropriate method contraception 5 . Urine sample take sent central laboratory baseline Ntx analysis 6 . Written informed consent . 1 . Bisphosphonate treatment within 4 week prior plan first study treatment 2 . Abnormal renal function evidence calculated creatinine clearance &lt; 30 ml/minute 3 . Poor venous access 4 . Metabolic bone disease 5 . Unable comply study procedure , especially reliable collection urine sample bone resorption marker measurements 6 . Estimated life expectancy &lt; 6 month 7 . Treatment systemic bone seek radioisotope within 3 month prior study entry 8 . Wide field ( hemibody ) radiotherapy within 3 month prior study entry 9 . Concomitant medication drug know affect bone metabolism 10 . Pregnancy breastfeed 11 . Current active dental problem include infection teeth jawbone ( maxilla mandibular ) , current prior diagnosis osteonecrosis jaw ( ONJ ) 12 . Recent ( within 4 week study entry* ) plan dental jaw surgery</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2010</verification_date>
	<keyword>metastatic breast cancer</keyword>
	<keyword>bone remodel marker</keyword>
	<keyword>zoledronic acid</keyword>
</DOC>